Terms: = Testicular cancer AND hCG AND Prognosis
145 results:
1. testicular cancer: new developments, molecular pathology, and current research keynote.
Lopez-Beltran A
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):204-207. PubMed ID: 37975918
[TBL] [Abstract] [Full Text] [Related]
2. Εmerging Biomarkers in the Diagnosis and Treatment of testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract] [Full Text] [Related]
3. [testicular tumours from a clinical point of view : What urologists and oncologists need to know from the pathologist about testicular cancer].
Oing C; Fankhauser CD
Pathologie (Heidelb); 2022 Nov; 43(6):434-440. PubMed ID: 36156132
[TBL] [Abstract] [Full Text] [Related]
4. [Biomarkers in testicular cancer.].
Mayor-de-Castro J; Aragón-Chamizo J; Caño-Velasco J; Hernández-Fernández C
Arch Esp Urol; 2022 Mar; 75(2):113-117. PubMed ID: 35332880
[TBL] [Abstract] [Full Text] [Related]
5. Glycan signatures for the identification of cisplatin-resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hcg).
Hires M; Jane E; Kalavska K; Chovanec M; Mego M; Kasak P; Bertok T; Tkac J
Cancer Med; 2022 Feb; 11(4):968-982. PubMed ID: 35044085
[TBL] [Abstract] [Full Text] [Related]
6. [ADENOCARCINOMA OF THE RETE TESTIS WITH METASTASIS OF THE PENILE AND LUNG: A CASE REPORT].
Noguchi T; Osaka K; Shibata Y; Koizumi M; Suzuki T; Kishida T; Okubo Y; Kameda Y
Nihon Hinyokika Gakkai Zasshi; 2022; 113(2):78-81. PubMed ID: 37081657
[TBL] [Abstract] [Full Text] [Related]
7. A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts.
Ataikiru UO; Iacob ER; Miron I; Popoiu CM; Boia ES
J Pediatr Endocrinol Metab; 2022 Mar; 35(3):363-371. PubMed ID: 34968016
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical analysis of testicular rhabdomyosarcoma].
Ye JF; Zhao L; Wang GL; Hong K; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1178-1182. PubMed ID: 34916701
[TBL] [Abstract] [Full Text] [Related]
9. Successful treatment of radiotherapy and apatinib in patient with mediastinal mixed non-seminomatous germ cell tumor: A case report.
Ren C; Zhao J; Kang L; Di Y; Qiu G; Wang Q
Medicine (Baltimore); 2021 Oct; 100(43):e27617. PubMed ID: 34713845
[TBL] [Abstract] [Full Text] [Related]
10. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
Che Y; Buddensieck C; Albers P; Lusch A; Winter C; Siemer RG; Hiester A
J Urol; 2022 Mar; 207(3):617-626. PubMed ID: 34694152
[TBL] [Abstract] [Full Text] [Related]
11. Late relapsing germ cell tumors with elevated tumor markers.
Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic importance of neutrophil-to-lymphocyte ratio in testicular cancer.
Arıman A; Merder E
Urologia; 2021 Aug; 88(3):200-205. PubMed ID: 33568012
[TBL] [Abstract] [Full Text] [Related]
13. Serum tumour markers in germ cell tumours: From diagnosis to cure.
Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
[TBL] [Abstract] [Full Text] [Related]
14. Does Determining Tumor Markers from the testicular Vein Enable Better Diagnosis and prognosis?
Zauner T; Heidler S; Lusuardi L; Albrecht W; Wimpissinger F
Urol Int; 2021; 105(3-4):264-268. PubMed ID: 33333530
[TBL] [Abstract] [Full Text] [Related]
15. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
Aydos U; Tahtaci G; Özgür Akdemir Ü; Özet A
Nucl Med Commun; 2020 Nov; 41(11):1199-1209. PubMed ID: 32796455
[TBL] [Abstract] [Full Text] [Related]
16. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract] [Full Text] [Related]
17. Is testicular microlithiasis a really innocent condition? Its effects on oncological outcomes of germ cell testicular cancer: An observational study.
Selvi I; Sarikaya S; Başar H
Arch Esp Urol; 2020 Apr; 73(3):215-229. PubMed ID: 32240112
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathologic features of testicular seminoma with syncytiotrophoblastic cells: Analysis of 3 cases and review of the literature].
Liang Y; Tu P; Wang X; Yi XM; Zhou XD; Shi QL
Zhonghua Nan Ke Xue; 2019 Jul; 25(7):642-646. PubMed ID: 32223107
[TBL] [Abstract] [Full Text] [Related]
19. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
[TBL] [Abstract] [Full Text] [Related]
20. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
[TBL] [Abstract] [Full Text] [Related]
[Next]
